|
|
|
시장보고서
Biochips (Industry forecasts for 2012 & 2017)
|
Abstract
US demand to rise 9.9% annually though 2012
The US market for biochip products and services will increase 9.9 percent per
year to $2.5 billion in 2012. Microarrays will sustain the largest portion of
product demand based on their consumable nature and expanding applications in
drug discovery, life science research, and clinical and forensic testing. DNA
chips will continue to lead microarray sales, spurred by widening use in the
identification and testing of potential new therapies and diagnostic targets.
However, laboratory and protein microarrays will provide faster growth
opportunities as the focus of drug discovery and life science research
activities shifts from genomics to proteomics.
Reagents & consumables to be fastest growing segment
Demand for biochip reagents and related consumables will increase at a fast
pace as gene expression, genotyping and protein analysis investigations become
increasingly complex. Fluorescent biomarkers, which identify disease pathways,
evaluate the effectiveness of potential therapies, and quantify drug toxicity,
will command the strongest growth opportunities.
The market for biochip instrumentation will expand moderately as
pharmaceutical and other life science laboratories upgrade equipment
capabilities to accommodate advanced genomic and protein analysis.
Multi-functional workstations that combine sample preparation, hybridization
and detection will generate the fastest gains based on performance and
convenience advantages.
Microarray analysis software will build demand as advancing technology
increases the amount and complexity of data obtained from genomic and
proteomic investigations. The best growth opportunities in this product group
will exist in analytical programs that enable experimental data to be compared
with information contained in large, publicly available databases developed by
academic institutions, government agencies and trade groups.
Lastly, biochip service revenues will rise at a strong pace as rapidly
changing technology expands the need of pharmaceutical and other life science
researchers for functional and technical support. Changing product development
strategies in the pharmaceutical, biotechnology and medical diagnostic
industries, coupled with anticipated increases in the availability of
government funding for agricultural, environmental and epidemiological
research, will boost revenue opportunities in this segment.
Study coverage
Details on these and other findings are included in the new Freedonia industry
study, Biochips. The study presents historical demand data (1997, 2002 and
2007) plus forecasts for 2012 and 2017 by biochip technology, product,
service, application and market. The study also considers market environment
factors, details industry structure, evaluates company market share and
profiles leading competitors.
Table of Contents
INTRODUCTION
GLOSSARY OF TERMS
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
- General
- Macroeconomic Trends
- Demographic Patterns
- Trends in Health Care
- Health Insurance Coverage
- Diseases & Disorders
- Acute Conditions
- Chronic Conditions
- National Health Expenditures
- Types
- Sources
- Medical Providers
- Acute Care Hospitals
- Outpatient Clinics
- Skilled Nursing Homes
- Physicians
- Patient Activity
- Acute Care Hospital Admissions
- Surgical Procedures
- Outpatient Episodes
- Diagnostic Tests
- Pharmaceutical Industry Trends
- Regulation
- Research & Development
- Product Shipments
- Therapeutic Classes
- Trends in Shipments
- Trends in In Vitro Diagnostics
- Regulation
- Research & Development
- Product Shipments
- Life Science Research Trends
- Funding
- Activities
- Biochip Market Overview
- Markets Served
- Demand Patterns
- US Trade
- International Markets
III. BIOCHIP TECHNOLOGIES
- General
- Genomic Technology
- DNA Structure
- Genetic Variants
- Gene Expression
- SNP Identification & Genotyping
- Proteomics
- Protein Structure
- Commercial Applications
- Biochip Production Methods
- Photolithography
- Microfluidic Technology
- Sample Preparation & Hybridization Processes
- Biochip Detection Methods
- Biochip Data Analysis
- Competitive Technologies
- Research Technologies
- In Vitro Diagnostic (IVD) Technologies
- Drug Discovery Technologies
IV. BIOCHIP PRODUCTS & SERVICES
- General
- Biochip Products
- Biochips (Microarrays)
- DNA Chips
- Applications
- Producers
- Protein Chips
- Applications
- Producers
- Laboratory Chips
- Applications
- Producers
- Biochip Reagents & Consumables
- Extraction Reagents
- Labeling Kits
- Other Reagents & Consumables
- Biochip Instruments
- Detection Instruments
- Technologies
- Products & Producers
- Production Instruments
- Production Methods
- Products & Producers
- Sample Preparation & Hybridization Instruments
- Sample Preparation Instruments
- Hybridization Instruments
- Biochip Software
- Open Programs
- Closed Programs
- Biochip Services
- Contract & Related Services
- Maintenance, Repair & Technical Support Services
V. BIOCHIP APPLICATIONS
- General
- Drug Discovery
- Gene Expression
- SNP Identification & Genotyping
- Proteomics
- Life Science Research
- In Vitro Diagnostic Testing
- Disease Management
- Forensic Medicine
- Drugs-of-Abuse Testing
- Other Applications
- Agriculture
- Defense & Military
- Industrial & Environmental Applications
VI. BIOCHIP MARKETS
- General
- Pharmaceutical Companies
- Market Trends
- Biochip Trends
- Biotechnology Companies
- Colleges & Universities
- Medical Providers
- Hospitals
- Clinical Laboratories
- Other Medical Providers
- Government Agencies
- Other Markets
VII. INDUSTRY STRUCTURE
- General
- Market Share
- Competitive Strategies
- Mergers & Acquisitions
- Licensing & Related Agreements
- Research & Development
- Marketing & Distribution
- Manufacturing Activities
COMPANY PROFILES
- Affymetrix Incorporated
- Agilent Technologies Incorporated
- Applera Corporation, see Applied Biosystems
- Applied Biosystems Incorporated
- Beckman Coulter Incorporated
- Becton, Dickinson and Company
- Bio-Rad Laboratories Incorporated
- bioMerieux SA
- BioTrove Incorporated
- Caliper Life Sciences Incorporated
- Cepheid
- Clontech Laboratories Incorporated, see Takara Holdings
- CombiMatrix Corporation
- Fluidigm Corporation
- General Electric Company
- Helicos BioSciences Corporation
- Illumina Incorporated
- Invitrogen Corporation
- Johnson & Johnson
- MDS Incorporated
- Micronics Incorporated
- Molecular Devices Corporation, see MDS
- Pacific Biosciences of California Incorporated
- PerkinElmer Incorporated
- QIAGEN NV
- Roche Holding Limited
- SEQUENOM Incorporated
- Siemens AG
- Solexa Incorporated, see Illumina
- Takara Holdings Incorporated
- Veridex LLC, see Johnson & Johnson
- Other Companies Mentioned in the Study
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY
SECTION II -- MARKET ENVIRONMENT
- 1 Macroeconomic Indicators
- 2 Population by Age Group
- 3 Health Insurance Coverage of the US Population
- 4 Acute Conditions by Type
- 5 Chronic Conditions by Type
- 6 National Health Expenditures by Type & Source
- 7 Medical Providers by Type
- 8 Patient Activity by Type
- 9 Pharmaceutical Research & Development Expenditures by Type & Object
- 10 Pharmaceutical Shipments by Therapeutic Class
- 11 In Vitro Diagnostic (IVD) Product Demand by Methodology & Type
- 12 Life Science Research & Development Expenditures by Objective &
Performing Sector
- 13 Biochip Product & Service Demand, 1998-2007
- 14 US Trade in Biochip Products
- 15 World Biochip Product & Service Demand
SECTION III -- BIOCHIP TECHNOLOGIES
- 1 Biochip Product & Service Demand by Technology
- 2 Gene Expression - Biochip Product & Service Demand
- 3 SNP Identification & Genotyping - Biochip Product & Service Demand
- 4 Proteomic & Related Technologies - Biochip Product & Service Demand
SECTION IV -- BIOCHIP PRODUCTS & SERVICES
- 1 Biochip Product & Service Demand by Category
- 2 Biochip Product Demand by Type
- 3 Biochip (Microarray) Demand by Type
- 4 DNA Chip (Microarray) Demand by Application
- 5 Protein Chip (Microarray) Demand by Application
- 6 Laboratory Chip (Microarray) Demand by Application
- 7 Biochip Reagent & Consumable Demand by Application
- 8 Biochip Instrument Demand by Type
- 9 Biochip Detection Instrument Demand by Application
- 10 Biochip Production Instrument Demand by Application
- 11 Biochip Sample Preparation & Hybridization Instrument Demand by
Application
- 12 Biochip Software Demand by Application
- 13 Biochip Service Demand by Type
SECTION V -- BIOCHIP APPLICATIONS
- 1 Biochip Product & Service Demand by Application
- 2 Drug Discovery Demand - Biochip Products & Services
- 3 Life Science Research Demand - Biochip Products & Services
- 4 In Vitro Diagnostic Testing Demand - Biochip Products & Services
- 5 Disease Management Demand - Biochip Products & Services
- 6 Forensic Medicine Demand - Biochip Products & Services
- 7 Drugs-of-Abuse Testing Demand - Biochip Products & Services
- 8 Biochip Product & Service Demand in Other Applications
SECTION VI -- BIOCHIP MARKETS
- 1 Biochip Product & Service Demand by Market
- 2 Pharmaceutical Industry Demand - Biochip Products & Services
- 3 Biotechnology Industry Demand - Biochip Products & Services
- 4 College & University Demand - Biochip Products & Services
- 5 Medical Provider Demand - Biochip Products & Services
- 6 Government Agency Demand - Biochip Products & Services
- 7 Biochip Product & Service Demand in Other Markets
SECTION VII -- INDUSTRY STRUCTURE
- 1 Biochip Revenues by Company, 2007
- 2 Selected Acquisitions & Divestitures
- 3 Selected Cooperative Agreements
LIST OF CHARTS
SECTION III -- BIOCHIP TECHNOLOGIES
- 1 Biochip Product & Service Demand by Technology, 2007
SECTION IV -- BIOCHIP PRODUCTS & SERVICES
- 1 Biochip Product Demand by Type, 2007
- 2 Biochip (Microarray) Demand by Type, 2007
- 3 Biochip Instrument Demand by Type, 2007
SECTION V -- BIOCHIP APPLICATIONS
- 1 Biochip Product & Service Demand by Application, 2007
- 2 Drug Discovery Demand for Biochip Products & Services by Type, 2007
SECTION VI -- BIOCHIP MARKETS
- 1 Biochip Product & Service Demand by Market, 2007
SECTION VII -- INDUSTRY STRUCTURE
- 1 Biochip Products & Services Market Share by Company, 2007
|
 |
